Secukinumab after anti-tumour necrosis factor-α therapy: a phase III study in active rheumatoid arthritis

E. Dokoupilová, J. Aelion, T. Takeuchi, N. Malavolta, P. P. Sfikakis, Y. Wang, S. Rohrer, H. B. Richards

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Secukinumab after anti-tumour necrosis factor-α therapy: a phase III study in active rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences